Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic…
$0.30+0.97%
报价 2026-11-06
市值
$27.4M
EV
$46.3M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -45.4%
$0.25$0.55
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| MLSSMilestone Scientific Inc. | $27.4M | +1.0% | +7.6% | 69.6% | – | – | – | |
| SABSSAB Biotherapeutics, Inc. | $275.7M | +3.1% | +50.0% | 0% | 0.9x | – | – | |
| NTRBNutriband Inc. | $67.5M | -0.4% | +3433.3% | 33.1% | – | – | – | |
| POCIPrecision Optics Corporation, Inc. | $53.6M | -1.3% | – | 9.7% | – | – | – | |
| MYOMyomo, Inc. | $47.9M | +1.7% | +11.0% | 68.4% | – | – | – | |
| HBIOHarvard Bioscience, Inc. | $38.1M | -1.2% | +3.1% | 53% | – | 11.2x | 7.4x | |
| MIRAMIRA Pharmaceuticals, Inc. | $24M | +5.6% | – | 0% | – | – | – | |
| IGCIGC Pharma, Inc. | $20.7M | +5.8% | +25.0% | 21.9% | – | – | – | |
| RVPRetractable Technologies, Inc. | $16.9M | -0.1% | – | – | – | – | – | |
| 同行中位数 | – | – | +25.0% | 21.9% | 0.9x | 11.2x | 7.4x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。